EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulation of lymphoma in vitro by CLP36 through the PI3K/AKT/CREB signaling pathway

Chao Lv, Guannan Chen, Shuang Lv

PeerJ · 2024

DOI: 10.7717/peerj.18693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Chao Lv und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Inner Mongolia People's Hospital, Hohhot, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Cyclic AMP Response Element-Binding Protein, Signal Transduction, Lymphoma. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CLP36 is also known as PDZ and LIM Domain 1 (PDLIM1) that is a ubiquitously-expressed α-actinin-binding cytoskeletal protein involved in carcinogenesis, and our current study aims to explore its involvement in lymphoma.

Methods

Accordingly, the CLP36 expression pattern in lymphoma and its association with the overall survival was predicted. Then, qPCR was applied to gauge CLP36 expression in lymphoma cells and determine the knockdown efficiency. The survival, proliferation and apoptosis of CLP36-silencing lymphoma cells were tested. Cell viability, proliferation and apoptosis were assessed based on cell counting kit-8 (CCK-8) assay, colony formation assay, EdU staining, and flow cytometry, respectively. Additionally, qPCR was used to calculate the expressions of proteins associated with metastasis and apoptosis, while immunoblotting was employed to determine the phosphorylation status of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/cAMP-response element binding protein (CREB).

Results

CLP36 expression was relatively higher in lymphoma, which was associated with a poor prognosis. Also, CLP36 was highly-expressed in lymphoma cells and the silencing of CLP36 contributed to the suppressed survival and proliferation as well as the enhanced apoptosis of lymphoma cells. Further, CLP36 silencing repressed the expressions of Cadherin 2 (CDH2) and Vimentin (VIM) yet promoted those of Bax and Caspase 3 in lymphoma cells, concurrent with the reduction on the phosphorylation of PI3K, AKT and CREB, all of which were confirmed to be positively correlated with CLP36.

Conclusion

This study, so far as we are concerned, provided evidence on the involvement of CLP36/PI3K/AKT/CREB axis in lymphoma, which may be contributive for the identification on the relevant molecular targets of lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktCyclic AMP Response Element-Binding ProteinSignal TransductionLymphomaLIM Domain ProteinsPhosphatidylinositol 3-KinasesCell ProliferationApoptosisHumansCell Line, TumorGene Expression Regulation, NeoplasticCell SurvivalCytoskeletal Proteins

Stichwörter der Autor:innen

CLP36LymphomaPI3K/AKT/CREBProliferationSurvival

Substanzen

Proto-Oncogene Proteins c-aktCyclic AMP Response Element-Binding ProteinLIM Domain ProteinsPhosphatidylinositol 3-KinasesCREB1 protein, humanCytoskeletal Proteins

Autor:innen und Institutionen

  • Medical Oncology, Inner Mongolia People's Hospital, Hohhot, China.
  • Hepatological Surgery Department, Tianjin First Central Hospital, Tianjin, China.

Zitieren

APA

Lv, C., Chen, G., & Lv, S. (2024). Regulation of lymphoma in vitro by CLP36 through the PI3K/AKT/CREB signaling pathway. PeerJ. https://doi.org/10.7717/peerj.18693

Vancouver

Lv C, Chen G, Lv S. Regulation of lymphoma in vitro by CLP36 through the PI3K/AKT/CREB signaling pathway. PeerJ. 2024. doi:10.7717/peerj.18693

BibTeX
@article{Lv2024,
  author = {Lv, Chao and Chen, Guannan and Lv, Shuang},
  title = {Regulation of lymphoma in vitro by CLP36 through the PI3K/AKT/CREB signaling pathway},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18693}
}
Kostenlos starten →